Physician profile
Tristan E Handler
NPI 1306059266
$18,773.03
in general payments reported to CMS, 2019-2025
46 companies · $2,836 in 2025
The $2,836 reported for 2025 was more than what 86% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,127 · 2020: $1,259 · 2021: $2,571 · 2022: $2,914 · 2023: $3,141 · 2024: $3,926 · 2025: $2,836.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,688 · Education: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,687.86 |
| Education | $215.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,406.96 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $3,234.88 | 2019-2025 | Xifaxan, Trulance, Plenvu |
| Janssen Biotech, INC. | $1,884.17 | 2019-2025 | Stelara, Tremfya, Remicade |
| Takeda Pharmaceuticals U.S.A., INC. | $1,375.55 | 2019-2025 | Entyvio, Gattex, Eohilia |
| Pfizer INC. | $1,198.05 | 2019-2025 | |
| Genzyme Corporation | $878.75 | 2022-2025 | |
| Redhill Biopharma INC. | $778.62 | 2020-2022 | |
| Qol Medical, LLC | $705.31 | 2021-2025 | Sucraid, Sucraid |
| Celgene Corporation | $615.69 | 2021-2024 | Zeposia |
| Lilly USA, LLC | $323.76 | 2024-2025 | Omvoh |
| Regeneron Healthcare Solutions, INC. | $312.69 | 2022-2025 | Dupixent |
| Gilead Sciences, INC. | $248.43 | 2019-2025 | Epclusa |
| Nestle Healthcare Nutrition INC. | $224.14 | 2021-2023 | |
| Shire North American Group INC | $217.08 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $210.66 | 2024-2025 | Iqirvo, Bylvay |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tristan Handler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.